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Background 
Atherosclerotic cardiovascular disease (ACVD) is still the leading cause of death in Australia 
and one of its contributing factors is Familial Hypercholesterolaemia (FH). FH is an autosomal 
dominant inherited condition that causes significantly raised total cholesterol and low-density 
lipoprotein cholesterol (LDL-c) levels which subsequently increase the chance of premature 
ACVD. When occurring in the heterozygous state, the prevalence of FH is 1 in 500 people1, 2 
and affected individuals have a 50% chance of passing the condition to their offspring.3 For 
men with FH, the risk of developing coronary heart disease before the age of 50 is 50% while 
for women it is 30% at age 60 years. The genetic aspect of FH and its contribution to the 
marked acceleration of ACVD means that young adults have much to gain from early 
diagnosis and treatment. Effective treatment with statin therapy reduces the significant lifetime 
exposure to high cholesterol levels as seen with FH. This reduction in ACVD events will largely 
offset the cost of prolonged treatment.4 
Most of the FH cases are caused by mutations in three identified genes generating countless 
number of gene variants. Hence, failure to detect a mutation does not exclude a diagnosis of 
FH. As a result, genetic testing for screening purposes becomes expensive and unfeasible. 
Under the current model of care (MoC) for FH in Australia, FH is diagnosed through a number 
of different routes5, 6 and managed mainly through hospital-based lipid clinics undertaking 
genetic testing particularly if the clinical features (phenotype) are highly suggestive of FH. 
Diagnosis has been shown to prompt action by patients.7 There are several tools for 
diagnosing FH clinically, with the Dutch Lipid Clinic Network Criteria Score (DLCNCS) being 
the tool of choice in Australia.5 The fundamental step to FH care is the identification of the 
index case or first family individual with the diagnosed condition. This triggers the domino 
effect with the screening of first degree relatives of the index case for FH, a process known as 
cascade screening. 
In Australia, over 80% of the population consult a GP at least once a year.8, 9 Since GPs 
request 91.8% LDL-c tests through a community based pathology laboratory10, and research 
has shown that it may be possible to use a serum LDL-c cut-off point alone to facilitate the 
detection of FH10, GP consultations therefore offer a unique opportunity to help detect 
unknown index cases of FH in the community.11 However, despite FH being easily detectable 
and its potential for early intervention, it is currently underdiagnosed and the 18- 40 year old 
target population in this study are amongst the least likely to be offered opportunistic lipid 
testing during routine primary care visits. This situation is unlikely to change unless the profile 
of the condition receives much greater prominence and the benefits and cost effectiveness of 
early intervention are brought to the attention of general practitioners (GPs) and practice 
nurses (PNs). 
The effectiveness of minimally invasive Point-of-Care Testing (POCT) in GP settings has 
been proven.12 POCT for lipids has considerable potential as an early detection test for FH in 
primary care.13, 14 The quick and efficient nature of the test alleviates the resulting increase in 
workload and required resources. This study builds on the earlier UK research15 and the 
experience gathered from our previous study whereby an electronic data extraction method 
was employed to retrospectively review patient records for possible FH among patients 
attending four Western Australian Primary Care practices.16 Information from our 
retrospective study together with the one outlined in this report, will help optimise detection 
of FH patients and increase the efficiency of a primary care FH MoC. 
Our aims for this study were (1) to trial the concept of opportunistic POCT for FH screening 
in 18-40 year old cohorts with a view to undertaking detection and management of index 
cases at the primary care level; (2) to assess the acceptability of POCT; (3) increase 
awareness of FH; and (4) assess the cost of proposed model of shared care. Through 
collaboration with a cardio-metabolic clinic, results from this study will feed into the 
processes and protocols for cascade screening, genetic testing and clinical services offered 
through the MoC in Australia. 
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Methods 
TARGET POPULATION 
A convenience sample of 18-40 year old patients attending two general practices in the Perth 
metropolitan area were recruited within a 6-month timeframe (4 May - 27 October 2015). 
Assuming that 30% of the target population will be eligible and consent to participant, and only 
one GP/practice will consent to participate, we aimed to recruit 500 patients over six months. 
Patients on cardiovascular medications were excluded from the study. 
 
PROTOCOL  
Patients presenting to GPs for any consultation were informed of the study and invited to 
participate. Upon written consent, patients were requested to provide some demographic 
information in a participant information sheet. The practice nurse (PN) or pathology 
phlebotomist (PP) then undertook a non-fasting finger-prick test (POCT) using the 
CardiocheckPA analyser12 to measure the patient’s lipid levels (Total cholesterol (TC), 
triglycerides (TG), high-density lipoprotein cholesterol (HDL-c), and low-density lipoprotein 
cholesterol (LDL-c)). If the LDL-c result was ≤ 4.9mmol/L, the PN or PP were requested to 
check with the GP to see if the patient required further advice. Patients with LDL-c level > 
4.9mmol/L were requested to revisit their GP for advice and to have a confirmatory fasting 
blood lipid test at a standard diagnostic laboratory. The PN and PP were also informed to 
recall patients with TG levels above the accuracy range of the non-fasting POCT test for a 
fasting blood test to ensure optimal medical management. 
If the fasting laboratory LDL-c result was ≤ 4.9mmol/L, the GP was requested to see the 
patient for general advice on how to maintain a low lipid level. If the fasting laboratory LDL-c 
result was > 4.9mmol/L, the patient would be assessed using the Dutch Lipid Clinic Network 
Criteria Score (DLCNCS) for FH. A DLCNCS of ≤5 classifies patients in the possible/unlikely 
FH category and a DLCNCS >5 classifies patients in the probable/definite FH category. 
Patients with LDL-c levels >4.9mmol/L and DLCNCS ≤5 would be managed at the discretion 
of their GP. Patients with LDL-c levels >4.9mmol/L and DLCNCS >5 (probable/definite FH) 
would be managed in a shared care model mainly by the GP with advice from the specialist. If 
high complexity FH patients (i.e. those with multiple uncontrolled risk factors, symptomatic 
CVD, pregnant or severe statin intolerance) were recruited, they would be managed through 
the specialist hospital care with feedback to their GP. As part of clinical care, first degree 
relatives (parents, siblings and offspring) of a screened FH index case would be contacted 
and offered FH screening. 
Staff at the two participating general practices were also informed of the study and invited to 
participate. At the end of the study, semi-structured interviews (face-to-face and telephone) 
were conducted with a subset of the patients recruited and all staff of the two participating 
general practices. Feedback sessions reporting the findings of the study to practice staff at 
both participating practices took place in early March 2016. A feedback letter and 
acknowledgement will be sent to all participating patients. 
The cost of the GP consultations and pathological laboratory test were Medicare billed as this 
is part of clinical management. There were no specialist costs as the GP did not use this 
service. All other POCT costs were funded by the study. Patients had no out-of-pocket 
expenses for the study purposes. 
This study was approved by the Human Research Ethics Committee at The University of 
Notre Dame Australia (approval number 015024F) and registered in the Australian New 
Zealand Clinical Trials registry (Registration number ACTRN12615000153516). 
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Results 
PATIENT CHARACTERIST ICS 
A total of 201 participants (66 males and 135 females) were recruited within the 6-month 
timeframe and completed the POCT finger-prick test. Two of these participants (1 male and 
1 female) were excluded as they fell outside the age range. Therefore this report will include 
data of only 199 participants (65 males and 134 females) and their demographic 
characteristics, as per the self-reported questionnaire, are listed in Table 1. 
 
Table 1: Self-reported demographic characteristics of participants who completed the POCT 
finger-prick test 
 
Self-reported demographics of participants 
Total number of participants n = 199 
Age 29 ± 6 y (min:18y, max: 40y) 
Gender 65 Males 
134 Females 
Index of relative socio-economic advantage 
and disadvantage, IRSAD 
 Lowest statistical area1 (SA1) range 
recruited 
 Highest SA1 range recruited 
 
 
SA1 min: 650, SA1 max: 1073 
 
SA1 min:1087, SA1 max: 1188 
Smoking status 
 Never smoked 
 Smoked but stopped > 10y ago 
 Smoked but stopped 5-10y ago 
 Smoked but stopped >1 but <5y ago 
 Smoked but stopped <12m ago 
 Smoker <1 packet/week 
 Smoker >1 packet/week 
 
n =124 (62.3%) 
n = 9 (4.5%) 
n = 6 (3.0%) 
n = 14 (7%) 
n = 11 (5.5%) 
n = 17 (8.5%) 
n = 18 (9.0%) 
Frequency of alcohol consumption in past year 
 Never 
 Monthly or less 
 2-4 times per month 
 2-3 times per week 
 >6 times per week 
 
n = 11 (5.5%) 
n = 40 (20.1%) 
n = 69 (34.7%) 
n = 67 (33.7%) 
n = 12 (6.0%) 
Number of drinks on a typical drinking day 
 None 
 1-2 drinks 
 3-4 drinks 
 5-6 drinks 
 7-9 drinks 
 >10 drinks 
 
n = 14 (7%) 
n = 92 (46.2%) 
n = 57 (28.6%) 
n = 22 (11.1%) 
n = 8 (4%) 
n = 6 (3%) 
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Self-reported demographics of participants 
Frequency of having >6 standard drinks on one 
occasion in past year 
 Never 
 < Once/Month 
 Monthly 
 Weekly 
 Almost daily 
 
 
n = 56 (28.1%) 
n = 86 (43.2 %) 
n = 39 (19.6%) 
n = 17 (8.5 %) 
n = 1 (0.5%) 
Family history of high cholesterol 
 Paternal side 
 Maternal side 
 Unspecified 
 
n = 2 
n = 2 
n = 3 
Patients on cardiovascular medication n = 0 
Weight (kg, n = 197), Mean ± SD (min : max) 71.15 ± 15.6 (46.0 : 130.0) 
Height (m, n =192), Mean ± SD (min : max) 1.71 ± 0.94 (1.5 : 1.95) 
Body mass index, BMI (kg/m2, n = 192), Mean 
± SD (min : max) 
24.17 ± 4.09 (16.46 : 38.37) 
 
POINT OF CARE TESTIN G (POCT)  
As a result of technical difficulties with the CardioCheck® machine and capillary tube, lipid 
levels were not obtained from all participants. Table 2 depicts the lipid profile of the patients 
tested. 
 
Table 2: Non-fasting lipid profile of POCT participants 
 Mean ± SD (min : max) 
POCT-LDL, mmol/L 2.096 ± 0.797 (0.21 : 4.30) 
POCT-TC, mmol/L 4.271 ± 0.872 (2.59 : 6.62) 
POCT-HDL, mmol/L 1.60 ± 0.475 (0.39 ± 2.59) 
POCT-TG, mmol/L 1.293 ± 0.709 (0.57 : 4.36) 
 
Recruitment Rate 
The total number of patients age 18 – 40y who visited the two participating medical centres 
during the study period was used as denominator to calculate the recruitment rate. A 
breakdown by gender is shown in table 3. 
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Table 3: Recruitment rate by gender during a 6-month period 
Medical 
Centre 
Gender No recruited No visited practice % recruited 
1 
 
Male 
Female 
Total 
41 
72 
113 
441 
711 
1152 
9.3 
10.1 
9.8 
2 
 
Male 
Female 
Total 
24 
62 
86 
1777 
2853 
4630 
1.4 
2.2 
1.9 
Overall  199 5782 3.4 
 
Technical Issues 
One major technical difficulty encountered during the study was a problem with the first batch 
of lancets supplied with the testing kits. This resulted in blood collection difficulties and many 
patients had to have a few attempts with finger prick testing before an adequate sample was 
obtained. This problem proved to be frustrating not just for the patient but also for the 
PN/Phlebotomist and GP involved and probably accounted for some loss of momentum at 
the commencement of the study. 
The problem was rectified after consultations with the kit supplier who acknowledged that the 
original lancets supplied were not adequate for the amount of blood required. A replacement 
batch of lancets rectified the problem but some patients were undoubtedly lost to the study 
as a result. In addition, the confidence of staff undertaking the process was hampered in the 
early phase of the study and could have contributed to lower than expected numbers being 
recruited. PNs compared this phase unfavourably with POCT for blood sugars levels and 
International Normalised Ratio (INR) in Warfarin management. Hopefully, lessons learned for 
future work. 
 
 
PATIENTS’  PERCEPTION S OF THE POCT 
PROCESS 
A subset of 34 participants was systematically selected for the semi-structured telephone 
interview. Table 4 shows the characteristics of the subset of participants attending the two 
medical centres. 
Table 4: Characteristics of the subset of participants attending the two medical centres 
 Number of 
Participant 
% of total 
respondents 
Patient Visit Type: 
 First time visits 
 < 1 year 
 >1 and <10 years 
 >10 years 
 
4 
3 
18 
9 
 
11.76 
8.82 
52.94 
26.47 
Choice of GP: 
 Whoever is available 
 Same GP all the time 
 2 GPs 
 First time at practice 
 
9 
16 
5 
4 
 
26.47 
47.06 
14.71 
11.76 
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Participants’ perspectives on the opportunistic nature of the test 
 
 
 
Overall, participants were not averse to being asked to participate in the study (Table 5). 
Participants thought it was fine and were not bothered to have their cholesterol levels 
opportunistically tested. Comments such as “Happy to do it as was already at the practice” 
(Patient 17), “Father has high cholesterol, I have Hashimoto’s, so wanted to know if T3 was 
working effectively in keeping my cholesterol level down” (Patient 14) and “was going for a 
skin check, so was fine” (Patient 107) were noted by the respondents. 
Four out of 34 participants (12% of sub-group) also mentioned that they were “happy to help” 
since it was a university research project. 
A couple of respondents (6% of sub-group) had mixed feelings about the test. One participant 
had agreed to participate for altruistic reasons and explained, “I would rather not do the test 
but I was happy to help” (Patient 59) and another one mentioned that they “…did not know 
what [I] was agreeing to at the time, but was ok with it” (Patient 65). 
 
Table 5: Breakdown of the participants’ perspectives on the opportunistic nature of the test 
Responses Number Percentage of total 
respondents (5) 
No issues 29 85.3 
Willing to help 9 26.5 
Other* 6 17.7 
*Other includes: motivated to do test due to family history of high cholesterol, convenience of 
already being at the practice, and reluctance to do test 
 
Participants’ perspectives on the process of POCT 
 
 
 
Overall, participants acknowledged that the process was easy and not a burden to them. 
They described it as being quite efficient, easy, fine and simple and professional. 
Participants particularly liked the fact that having the test done was made easier by them 
already having an appointment to see the GP. As some explained, “I did the test and then 
went to see the doctor for the rest of my appointment” (Patients 20 and 32) and “the doctor 
was running late and so I did the test first and did not wait any longer” (Patient 98). 
The majority of the participants also thought that the test was quick and easy. Some even 
mentioned that it was an “in and out job” or “really quick test”. However, the process did not 
Key Findings: 
 Patients were not bothered about being asked to do the POCT test even if they 
came to the practice with a different issue 
 Patients were happy to help research and the University and were keener on the 
study when a close family member had known high cholesterol levels. 
Key findings: 
 Participants felt that the process was easy and quick 
 Issues with wait time and test were due to glitches with the blood capillary tube 
 Participants were not always referred back to their GP to have their results 
explained 
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go smoothly for all. A few participants mentioned that “the paperwork took a bit of time”, that 
“the test was supposed to be fast, but was late”, and that they had to wait for a long time, “an 
extra 30-45 minutes instead of the five minutes as was told” (Patient 21). 
The disappointment and frustration were due to difficulties in drawing blood. As one patient 
said, “it took 30 minutes as they could not get blood off my finger. Then they finally got it” 
(Patient 4). 
Another mentioned that “it was a bit of a pain as it was hard to get blood. They had two to 
three attempts before they could fill up the capillary tube” (Patient 6). Two (out of 34) 
participants explained that they were disappointed as despite the multiple attempts, they still 
did not get enough blood for analysis and thus no results. 
Several participants (26% of sub-group) highlighted a few issues with the process of testing. 
They would have preferred the finger-prick test to be more straight forward instead of milking 
the finger. One participant (Patient 31) explained that he “had to run his hand under hot 
water, then it was fine”. Another felt that they should have been given more information on 
the results and commented that “the test was easy but I did not know what was going on. I 
did not know what the results meant. I had seen the GP then got the test done” (Patient 
146). 
 
Participants’ perception on the adequacy of information received 
 
 
 
In general, nurses and the phlebotomist were the ones who explained the study to the 
participants before carrying out the finger-prick test. In one of the participating practices, 
nurses were in charge of the finger-prick test, while in the other, a phlebotomist was in 
charge. 
Overall, patients had their questions answered. Only one patient who got their test done 
close to closing time did not get to ask questions nor had the study explained to them. Only a 
few patients did not have many questions or did not remember much of the test. Patients 
were urged to go back to their GPs to have their results explained; however, we had no 
control on information given to patients by the nurses or the phlebotomist. One patient 
(Patient 167) in particular did not find the phlebotomist’s explanation adequate: “I did have a 
slice so it was a non-fasting test. I was worried as the phlebotomist told me that my 
cholesterol level was really high. So I had my GP to check it. I did a fasting [blood] and was 
all good. I have high HDL, so overall fasting cholesterol was high. But I would have preferred 
if the GP did the explanation not the phlebotomist, as the GP would know more”. 
 
Participants’ suggestions on how to improve the process in the future 
 
 
 
The majority of the participants had no suggestions as to how to improve the point of care 
testing. But if they did comment, participants gave good feedback about the process. They 
thought it was quick, very streamlined, and all handled as expected. Only a few gave 
Key findings: 
 Mostly nurses and the phlebotomist explained the study 
 Some patients would have preferred the GP to explain the results 
Key findings: 
 Participants in general were happy about the process and had no further 
suggestions 
 Some of the suggestions put forward included having an explanation sheet for the 
results, using better equipment, and getting more staff on-board for the finger-prick 
test 
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negative feedback about the test. A couple of participants (6% of sub-group) suggested 
having a sheet explaining the results and a process guiding who explains the results to the 
participant, while others commented on the difficulties experienced in having the test done, 
with comments such as: “I seem to have been the first patient. I just had issues getting blood 
from my finger” (Patient 8) and “get another staff on it to speed up the process as was told it 
would take only five minutes but it took much longer” (Patient 65). Another two participants 
(6% of sub-group) felt that the tests could be done by venipuncture on people who already 
have a referral for blood tests or on those who come for injections. 
 
Participants’ perceptions on the benefits of the study 
 
 
 
All but three of the participants (n = 31) interviewed thought that the study was beneficial. 
The three differing participants thought that the study was not beneficial at this point in time 
as their test showed normal cholesterol levels. 
The reasons stated by participants to justify the value of the study can be grouped in the four 
categories as follows: 
1. Opportunistic – Participants liked the fact that they were asked to have their 
cholesterol tested opportunistically and that getting the test done made them more 
aware of their health. One participant even said he was “happy with the test, and 
would come again” (Patient 8), and another said “I think more people should do it” 
(Patient 65) 
2. Age – A few participants understood that their age group did not routinely get 
asked to do blood tests and that it was good to be able to get tested 
3. On-the-spot results – Participants liked the fact that they could get their results 
instantly. 
4. Family history of high cholesterol levels – A few participants had a family history of 
cholesterol and therefore were pleased to have their cholesterol levels tested. One 
participant said “I have a history of high cholesterol in the family. I’m happy to have 
current results. Very pleased” (Patient 47). Another said “Mum has high 
cholesterol. It was good to find out about my own levels” (Patient 137). 
Two of the 34 participants interviewed did not get their test results as their blood sample 
quantities were insufficient. However, they still reported that the study was beneficial. 
 
 
GENERAL PRACTIT IONER S’  PERCEPTION OF 
THE POCT PROCESS 
Sixteen of the 18 participating general practitioners (GPs) were interviewed. One GP had a 
conflict of interest and was therefore excluded from the interviews and the other GP could 
not be reached. Since no index cases were identified, questions regarding family tracing 
were omitted from the interviews. 
 
  
Key findings: 
 Overall, participants thought that the study was beneficial 
 The reasons stated by participants to justify the value of the study could be 
grouped in four categories: Opportunistic, age, on the spot results, and family 
history of high cholesterol levels. 
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General Practitioners’ perspectives on the process of POCT 
 
 
 
Eighty seven percent of the general practitioners interviewed reported that the process was 
fine, straight forward and easy to implement. One doctor mentioned “I think the process was 
good…It is a new thing to do as a practice for us… It was a learning curve” (GP 15) and 
another agreed that “most people who got the test done were younger people whom I would 
not have been too concerned about high cholesterol; but I guess they are the people we 
want to target” (GP 10). Thirty one percent of the GPs interviewed also thought that the 
process was well received and that patients “were really interested in finding out their 
cholesterol levels” (GP 7). 
However, 19% of the GPs interviewed did admit that it was hard to remember to enrol 
patients in the study. One said “I must be honest. At the start, I kept forgetting to do it” (GP 
12) and another GP mentioned “Good test to do, no extra time; it is the process of 
remembering to enrol them in the study” (GP 7). 
Three of the 16 GPs interviewed agreed that the nurses and the phlebotomist had some 
technical difficulties at the start of the study. “The machine and pipettes were difficult to use 
and were not as user friendly as thought” was the general comment and one GP also said 
that “the paperwork took time” (GP 5). 
GPs observed that only a few patients declined to participate and that it was either because 
they recently had their cholesterol levels tested or the wait time for the blood test was too 
long. 
Two of the 16 GPs interviewed had little involvement with the study. 
 
Impact of the study on the general practitioners’ consultation time 
 
 
 
All but two of the general practitioners interviewed (88% of sub-group) reported that the study 
did not prolong their consultation time. “On average took two minutes”, or “not much time”, or 
“quite easy to do in terms of squeezing the POCT in an appointment time slot” were 
mentioned. Five of 16 GPs (31% of sub-group) also remarked that the POCT mostly 
impacted on reception staff and the nurse time. 
Only two doctors felt that the study took some time. One said that “nurses often would knack 
patients from me [the doctor] at the time I would call to see them. So I got behind [with my 
work]” (GP 4). 
 
  
Key findings: 
GPs reported that 
 the process was straight forward and easy to implement 
 it was hard to remember to enroll patients 
 the study was well received and patients would only decline if they recently had 
a blood test or if the wait time for the finger-prick test was too long 
Key findings: 
 All but two doctors felt that the study did not prolong their consultation time 
 On average it took two minutes to explain the study 
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General Practitioners’ perspectives on the addition of POCT to their role 
 
 
 
There was no unanimous answer to this question. While many general practitioners (56% of 
the sub-group) stated that the POCT can be part of their role, 50% of those interviewed said 
that it was not a straight forward decision and would depend largely on the medical 
circumstances of the patient or whether they were regular patients as opposed to one-off visit 
patients. 
“We cannot overburden people. We are already opportunistically asking people about their 
Pap smear and blood pressure. Adults do not come to GPs often. We do not want to harass 
them. We need to pick up what is important” (GP 1). 
“I will take into context if people came with a history of FH, then I would do it. Otherwise I will 
take into context. I will not inject it [POCT] unless there is some peripheral condition and the 
patient is worried about it” [sic] (GP 6). 
Two of the doctors interviewed were not in favour of the POCT. One said that “there are so 
many things to negotiate in a consult that it will not be feasible to do point of care testing as a 
GP in a consult” (GP 10). The other affirmed that “[they are] not particularly looking into doing 
it unless has a good reason to do it. Certainly not if just financial benefit from doing it. As often 
point of care testing has been done because there’s been financial reward attached to it” 
(GP8). 
 
General practitioners’ thoughts on whether Familial Hypercholesterolaemia should be 
managed in general practice and its associated benefits and challenges 
 
 
 
Only one general practitioner thought that managing FH in general practice would be difficult. 
Eighty eight percent of the doctors interviewed stated that FH could and should be managed 
in general practice provided clear guidelines are set and GPs are educated on the topic. 
However, they would still send the patient to the FH clinic should they encounter a resistant 
case. One GP said: 
“If have good, clear guidelines for how things are best managed, when do people have to see 
a specialist and what the current recommendations are [then FH could be managed in general 
practice]” (GP 2) 
Others have said: 
“Needs to have clear guidelines of what test needs to be done…. Guidelines on family tracing, 
how to go about that, how to encourage people to do it” (GP 7) 
“The more information you get, the more confident you become. Recording materials, 
Key findings: 
 No unanimous answer. Some were for and others against the concept 
 Decision will depend on the medical circumstances of the patient 
Key findings: 
 FH could and should be managed in general practice provided clear guidelines are 
set and GPs are educated on the topic 
 GPs agree that resistant cases should be sent to the FH clinic 
 If managed in general practice, it will be easier to follow up patients and their 
families 
 Genetic counselling should be available at the practice should the POCT 
process be rolled out 
 Time factor and lack of experience on FH were mentioned as challenges 
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talks/presentations to educate GPs on FH is needed. Fortnightly magazines, with updates and 
references will evoke passive learning” (GP 12). 
And, 
“If ought to be managed in GP land, would have to be something GPs are educated about” 
(GP 10) 
One GP (GP 8) also mentioned that it was important to make genetic counselling available at 
the practice should the POCT process be rolled out.   
Apart from taking the pressure off the tertiary system, doctors agreed that benefits revolve 
mostly around the ease of patients visiting and the holistic approach, and better continuity that 
general practitioners provide. One doctor mentioned: “We would be seeing them [patients] 
otherwise, so it could be opportunistic. If they are not being followed up or if they have not 
attended an appointment, we could say ‘by the way, we have not checked you; we have not 
seen you for ages’. Also you might know the family members, so you might treat the whole 
family. Also, it is easier for the patient [to go to their GP] than going to a new place” (GP 16). 
Another GP mentioned: “We like to look after families, it [FH] is related to families. We want 
people to see general practice as their medical home, so therefore they should identify all 
their problems that they can with general practice. There are a lot of advantages to do it” (GP 
15). 
In terms of challenges, doctors mentioned the time factor and their lack of experience with 
FH. As one doctor pointed out: 
“It is purely a time factor. Patients come and see well-established doctors with a list of things 
they want dealt with. It is often in 15 minutes. The reason you do not have time in the 15 
minutes, the list that they have got, let alone the point of care testing” (GP15). 
Other similar comments included “challenges will be the increase in workload”, “when the 
nurse was not familiar at the beginning, it took longer. We needed the nurse with other things 
and there was a conflict of time”, “Challenges will be the increase in workload”. They agreed 
that if POCT were to roll out in general practice, they would need more support.  
In addition to the above challenges, two of the 16 doctors interviewed felt that for those 
patients who have just moved to Perth, it would be difficult to get a background picture to 
compute their Dutch lipid profile. Another GP (GP 11) also mentioned that since most FH 
cases are asymptomatic, it will be harder for doctors to convince patients to go on 
medications.  
 
General practitioners’ perspectives on working with other practice staff 
 
 
 
Sixty nine percent of the doctors interviewed thought that working with the other practice staff 
for this study was no different to their other day-to-day activities. Twenty five percent of the 
GPs interviewed did mention that the receptionists, nurses and the phlebotomist did the bulk 
of the work and did not have to rely on the doctors. One even said that “if it was harder, I will 
not do it as it feels like I am running out of time” (GP 6). Another mentioned that POCT 
“needs ease of implementation, or else it will not work” (GP 3). 
However, 25% of the doctors interviewed still felt that the POCT process did not work well as 
it was too time consuming and needed better leadership in the practice. One doctor said that 
“‘it held up the treatment room at times. Nurses would be busy doing this and I would want 
the nurse for something else… More occasionally patients were with the nurse and not 
Key findings: 
 GPs agree that working on the POCT with other practice staff was no different to 
the other day-to-day activities 
 POCT needs ease of implementation and good leadership 
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ready” (GP 4). Another said “I think the reasons why it did not work so well in our practice 
was mostly to do with not having good leadership within the practice for it. I do not think it 
was anything to do with the design of the study, the research at the University, the 
researcher or our staff. I think it was just lack of leadership in our practice” (GP 15). 
Getting a GP champion was also suggested: 
“In everything that you roll out in general practice, you need a GP champion in the practice. 
That is what we found with everything and whenever, I have thought 'let's just see how it runs 
with this person, that person taking over’, somehow it might work for a day or two when it is 
on people's mind, but it doesn't stay without a GP champion. For example in our practice, we 
have a GP champion for diabetes. That works when the person is there and when the person 
is not there; it starts to fade away again” (GP15).  
 
 
NURSES’  PERCEPTIONS OF THE P OCT 
PROCESS 
Five nurses and one phlebotomist completed the semi structured interviews. Since no index 
cases were identified, questions regarding family tracing were omitted from the interviews. 
The nurses and the phlebotomist will be referred to as PN in this report. 
 
Nurses’ perspectives on the process of POCT 
The nurses and the phlebotomist working on the study were not unanimously in favour of the 
process for the POCT. Half of the group interviewed thought it was a good and straight 
forward process while the other half felt it was lengthy and fiddly. One of the nurses said: “It 
was a pain in the bum. It started badly when it was introduced, the timing of it (flu season)”. 
However, most of the antagonisms were due to internal politics at the practice and getting to 
know how to use the machine and implement a recruitment process. 
 
Impact of the study on the nurses’ consultation time 
Some nurses admitted that they were not directly involved. For those who were involved in 
the recruitment of patients and their finger-prick test, the time it took per patient depended on 
whether the patient had filled out the forms and whether they were an easy bleed. The 
lancets and capillary tube used were a challenge and contributed to the lengthy blood test. 
But on average, nurses and phlebotomist said it only took about five minutes. 
While the study plan was to have reception staff identify and invite patients to participate in 
the study, one nurse, however, was more involved with patient recruitment and was not 
impressed with the increased workload. They said that “it came back to the nurses. If the 
nurses did not do anything, nothing happened. A lot of it just was unrealistic for reception 
staff to be able to ask patients because of what they need to do out there” (PN 1). 
 
Nurses’ perspectives on the addition of POCT to their role 
Two nurses out of six said that they do not see the point of care testing being included in 
their role as practice nurses. While one thought that there were too many things already 
being done opportunistically in general practice, the other did not feel it was something 
worthwhile to conduct in the selected age group. 
“Not role as a nurse, not in this practice…Through reading, I did not see anyone would fit the 
criteria, so did not think ‘wow’ ” (PN 1). 
Others felt that the finger-prick test is an easy test and thus would be manageable to include 
in their role. One nurse said “if the test [lancet and capillary tube] was perfected, it would be 
better” (PN 3), and another mentioned “it is about putting it in one’s timeframe and workload” 
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(PN 6). 
 
Nurses’ thoughts on whether Familial Hypercholesterolaemia should be managed in 
general practice and its associated benefits and challenges 
 
 
 
Nurses thought that it was a good idea to have FH managed in general practice. They felt it 
would greatly benefit patients by providing a more accessible and relaxed atmosphere as 
well as more opportunities to see different age groups. 
However, they felt that nurses need to be educated if they were to doing the POCT. One 
even said that a participating phlebotomist or nurse would be needed for it to work. Only one 
nurse opposed to the idea and felt that “the survey failed to grab me in the first place” (PN 1), 
and another felt it should be treated at both general practice clinics and primary health care 
settings. Time constraint was the general challenge foreseen and one nurse felt the onus is 
on the GP to recruit patients. 
 
Nurses’ perspectives on working with other practice staff 
There was no consensus to this question. Two of the six participating PN thought that 
working with GPs and other staff for this study was no different than usual. It worked fine and 
just needed to encourage the receptionists who were busy to identify patients. 
Two did not give answers applicable to the question and the others felt that it did not work 
smoothly. 
One said that “we need to convince whoever owns the practice that the study is worth doing” 
(PN 1), another said “some GPs were already doing other studies and thus were not as 
keen” (PN 2). 
 
Nurses’ suggestions to improve the process in the future 
Nurses and the phlebotomist gave a few suggestions to improve the process. These 
included: 
 Preventative health education for the patients. For example leaflets to explain what 
the cholesterol levels meant. 
 Education package for the staff – Cheat sheets and other materials to allow staff to 
refer back to 
 Better way to invite patients to have their cholesterol tested opportunistically 
 Factor the test into staff day to day work 
 Have a better capillary tube 
 
  
Key findings: 
 All (83%) but one nurse were in favour of FH being managed in general practice 
 Nurses felt that it would benefit patients by providing a more accessible 
atmosphere 
 Time constraint and educating nurses on the topic were the foreseen challenges 
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NON-MEDICAL STAFF (RECEP TIONISTS )  
PERCEPTIONS OF THE POCT PROCESS 
Eight receptionists (RC) completed the semi structured interview. 
 
Receptionists’ perceived degree of difficulty to target patients 
Half of the reception staff interviewed felt that it was easy to remember to target patients from 
the specified age group. They used the booking system to check the patient’s age and to put 
alerts to remind themselves. 
One said “Was easy as need to check patient’s details anyway, so was easy for us to do” 
(RC 1). 
Another said “I kind of put little notes/alerts for me in the morning that this person might be 
the right age” (RC 6). 
The other staff on the other hand, felt it was difficult to remember especially when working 
part-time or when busy at the practice. One staff mentioned that “some days were a bit 
challenging because of the nature of our business… we are quite busy and it was hard to 
remember, in a professional way, to offer people the form” (RC 8). 
Another said “because I am part-time, am not here all the time. It was not easy to remember. 
Sometimes got busy with files and things and last thing on your mind is to do a survey” (RC 
2).  
 
Receptionists’ perceived degree of difficulty to get patients to read the information 
Seventy five percent of the reception staff said that it was difficult to get patients to read the 
information due to the combined length of the information sheet, consent form and 
participation form: 
“Long form. Lots of patients found that” (RC 6). 
“A lot of them looked and said ‘do I really need to read all of that?’ and I said ‘it is advisable, it 
will give you some knowledge on why it’s being done’. But told them it is optional if they want 
to participate or not. A lot of them pushed it aside and said no. As soon as they saw they had 
all that to read, they went ‘nah, I haven’t got the time’ ” (RC 3). 
Some staff said that it was OK to get patients to read the information. One said “pretty good. 
They would read it” (RC 7), one other mentioned that it all depended on whether the patient 
had time, and another said it was “50/50” (RC 4). 
 
Impact of the study on the receptionists’ time 
The majority of the staff (88%) felt that the process did not take much time. One mentioned 
that the patients just took the form and read. However, this was not always the case and a 
few staff said that it did take some time to explain the study to patients and also to remember 
who should be given the form. 
One receptionist explicitly said “Yes, because you have to try to explain it and when you don’t 
have a medical background, it is a bit hard to ask somebody to do something” (RC 2). 
 
Receptionists’ suggestions to improve the POCT process 
 
 
 
 
Key findings: 
 Have GPs more involved in the study and having a dedicated person to do 
the POCT were mentioned by more than one staff (63% of sub-group) 
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A few suggestions were given to help improve recruitment for future studies. “To increase 
doctors’ involvement” and “to have a dedicated person to do the Point of Care Testing” were 
the only suggestions mentioned by more than one staff (63% of sub-group). 
Other suggestions were: 
 Targeting specific gender 
 Having a pop up system to remind staff of the suitability of patients for the study 
 Make the forms shorter 
 Recruit from other locations such as pharmacies 
 Recruit from practices that see more patients of the specified age group 
 
Other issues raised by receptionists 
Two reception staff reiterated the fact that receptionists were not well placed to recruit 
patients. 
One mentioned: “It was not always easy to target this age group. Don’t think reception 
should do this. Maybe the nurse as they have more access to the patient’s file” (RC 2). 
Another said: “The way it has been tried at the front desk of a doctor’s surgery is not the 
best way. Eighty percent of people coming are unwell, grumpy and not accommodating” (RC 
3).
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Discussion 
The overarching aim (Aim 1) of the study was to assess feasibility of identifying incident index 
cases of familial hypercholesterolaemia (FH) in younger patients presenting routinely to GP 
using opportunistic screening and point-of-care testing (POCT). Only 3.4% of the age group 
presenting was captured for screening with a sample size of 199 instead of the 500 required. 
It was not unexpected therefore that no cases of FH were identifiable in the period of the 
study. Patients who participated provided useful feedback in regard to Aims 2 and 3. 
With regard to assessment of acceptability of POCT (Aim 2), GPs felt overall it was a straight 
forward process which could be implemented into usual practice. However, the medical 
circumstances of the patient or whether they were regular or one-off patients would determine 
the ease with which this was done. PNs felt similarly that POCT was not overly time 
consuming but felt it added to their already busy workload. One limiting factor that had a 
negative impact in the early phase of the study was the supply of equipment not suitable for 
purpose. Both GPs and PNs said the team approach adopted with other practice staff was no 
different to their day-to-day activities. Other practice staff felt the research process i.e. number 
of forms to read and sign made it difficult to recruit patients. Identifying patients was not 
difficult. This could be done through practice software. Overall, patients acknowledged that the 
process was easy and not a burden to them. Patients were accepting and satisfied with 
explanations given to them about the point of the study and process. They liked the fact that 
the results were given to them immediately. 
With regard to awareness of FH (Aim 3), the majority of the doctors thought that FH could and 
should be managed in general practice provided clear guidelines are set and GPs are 
educated on the topic. If they encounter a hard to manage (resistant) case, they would still 
send the patient to the specialist clinic. Like GPs the PNs believed FH should be managed in 
general practice. They also believed that better clinical and patient education of the problem 
would help increase identification and awareness of FH. The fact that patients were asked to 
have their cholesterol tested opportunistically made them more aware of their health. It also 
brought home the fact that that the targeted age group does not routinely get asked to do 
blood tests and patients felt that it was good to be offered the opportunity. A few participants 
had a family history of cholesterol and therefore were pleased to have their blood tested. 
No FH cases were detected hence there were no patients referred for shared care. Resource 
use / costings were not undertaken (Aim 4). 
KEY F INDINGS  
 POCT is feasible in implementation and acceptable within a GP setting provided 
there is good engagement among practice staff (reception staff, practice nurses, 
GPs) 
 Increasing awareness of the FH in the community will be a key factor in improving 
detection and management 
 Encourage younger age group blood testing in patients with a family history of 
premature coronary artery disease 
 For undertaking research, it is important to: 
o Have a dedicated research person to work with practice staff 
o Have a research study champion from within the practice 
o Ensure research protocol fits with day-to-day running of the practice 
o Minimise paperwork and not overly burden participants 
 
FOLLOW-ON FUTURE PLANS  
A larger FH study looking at implementing a method of care in general practice is being 
undertaken within Western Australia with a plan to extend to other States through NHMRC 
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funding. Following on from the lessons learned in this proof of concept study we are holding 
community conversations hosted through the Consumer and Community involvement 
program (http://www.involvingpeopleinresearch.org.au/) to determine how best to 
implement the study in the general practice setting. 
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